These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65. Factor H facilitates the clearance of GBM bound iC3b by controlling C3 activation in fluid phase. Paixão-Cavalcante D; Hanson S; Botto M; Cook HT; Pickering MC Mol Immunol; 2009 Jun; 46(10):1942-50. PubMed ID: 19411110 [TBL] [Abstract][Full Text] [Related]
66. C3 glomerulonephritis and autoimmune disease: more than a fortuitous association? Alexander MP; Fervenza FC; De Vriese AS; Smith RJH; Nasr SH; Cornell LD; Herrera Hernandez LP; Zhang Y; Sethi S J Nephrol; 2016 Apr; 29(2):203-209. PubMed ID: 26187133 [TBL] [Abstract][Full Text] [Related]
67. C5 nephritic factors drive the biological phenotype of C3 glomerulopathies. Marinozzi MC; Chauvet S; Le Quintrec M; Mignotet M; Petitprez F; Legendre C; Cailliez M; Deschenes G; Fischbach M; Karras A; Nobili F; Pietrement C; Dragon-Durey MA; Fakhouri F; Roumenina LT; Fremeaux-Bacchi V Kidney Int; 2017 Nov; 92(5):1232-1241. PubMed ID: 28712854 [TBL] [Abstract][Full Text] [Related]
68. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome. Servais A; Frémeaux-Bacchi V; Lequintrec M; Salomon R; Blouin J; Knebelmann B; Grünfeld JP; Lesavre P; Noël LH; Fakhouri F J Med Genet; 2007 Mar; 44(3):193-9. PubMed ID: 17018561 [TBL] [Abstract][Full Text] [Related]
69. Complement dysregulation in glomerulonephritis. Kaartinen K; Safa A; Kotha S; Ratti G; Meri S Semin Immunol; 2019 Oct; 45():101331. PubMed ID: 31711769 [TBL] [Abstract][Full Text] [Related]
70. A novel CFHR5 fusion protein causes C3 glomerulopathy in a family without Cypriot ancestry. Medjeral-Thomas N; Malik TH; Patel MP; Toth T; Cook HT; Tomson C; Pickering MC Kidney Int; 2014 Apr; 85(4):933-7. PubMed ID: 24067434 [TBL] [Abstract][Full Text] [Related]
71. Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Pickering MC; Cook HT; Warren J; Bygrave AE; Moss J; Walport MJ; Botto M Nat Genet; 2002 Aug; 31(4):424-8. PubMed ID: 12091909 [TBL] [Abstract][Full Text] [Related]
72. Treatment of C3 glomerulopathy with complement blockers. Vivarelli M; Emma F Semin Thromb Hemost; 2014 Jun; 40(4):472-7. PubMed ID: 24799307 [TBL] [Abstract][Full Text] [Related]
74. Dense deposit disease in a child with febrile sore throat. Conti G; De Vivo D; Vitale A; Fede C; Santoro D Saudi J Kidney Dis Transpl; 2017; 28(4):925-928. PubMed ID: 28748900 [TBL] [Abstract][Full Text] [Related]
75. Coding and Noncoding Variants in CFH Act Synergistically for Complement Activation in Immunoglobulin A Nephropathy. Guo WY; Liu QZ; Zhu L; Li ZY; Meng SJ; Shi SF; Liu LJ; Lv JC; Hou P; Zhang H Am J Med Sci; 2018 Aug; 356(2):114-120. PubMed ID: 30219152 [TBL] [Abstract][Full Text] [Related]
76. Complement factor H deficiency and endocapillary glomerulonephritis due to paternal isodisomy and a novel factor H mutation. Schejbel L; Schmidt IM; Kirchhoff M; Andersen CB; Marquart HV; Zipfel P; Garred P Genes Immun; 2011 Mar; 12(2):90-9. PubMed ID: 21270828 [TBL] [Abstract][Full Text] [Related]
77. Hypocomplementemic type II membranoproliferative glomerulonephritis in a male patient with familial lecithin-cholesterol acyltransferase deficiency due to two different allelic mutations. Sessa A; Battini G; Meroni M; Daidone G; Carnera I; Brambilla PL; Viganò G; Giordano F; Pallotti F; Torri Tarelli L; Calabresi L; Rolleri M; Bertolini S Nephron; 2001 Jul; 88(3):268-72. PubMed ID: 11423760 [TBL] [Abstract][Full Text] [Related]
78. Rare Functional Variants in Complement Genes and Anti-FH Autoantibodies-Associated aHUS. Valoti E; Alberti M; Iatropoulos P; Piras R; Mele C; Breno M; Cremaschi A; Bresin E; Donadelli R; Alizzi S; Amoroso A; Benigni A; Remuzzi G; Noris M Front Immunol; 2019; 10():853. PubMed ID: 31118930 [TBL] [Abstract][Full Text] [Related]
79. The complement fitness factor H: role in human diseases and for immune escape of pathogens, like pneumococci. Zipfel PF; Hallström T; Hammerschmidt S; Skerka C Vaccine; 2008 Dec; 26 Suppl 8():I67-74. PubMed ID: 19388168 [TBL] [Abstract][Full Text] [Related]